The Stakes Are High For Women’s Health Care Under Trump

Now that America has elected Donald J. Trump as their 45th president, how might the New York entrepreneur’s administration affect women and children in the next few years? Some of this is pure conjecture, since Trump’s policy talks have been notably short on details. Trump has, however, repeatedly said he intends to repeal most of the Affordable Care Act, or Obamacare, which would have grave effect on hundreds of thousands of families, if not more. Since 2010, the ACA has cut in half the number of uninsured citizens to a historic low of 8.6 percent of citizens, or 27.3 million people . A 2015 Congressional Budget Office study said that repealing the program would eliminate insurance coverage for about 22 million in 2017, and coverage of birth control and critical prenatal care might no longer be offered.

Disclosure Rules Don’t Stem Flow Of Pharma Cash To State’s Doctors

Dozens of Connecticut doctors accepted six-figure payments from drug and medical device manufacturers in 2015 for consulting, speaking, meals and travel, with six of the 10 highest-paid physicians affiliated with academic institutions, new federal data show. The top 10 doctors – less than 0.1 percent of the 11,000 who received payments – took in $3.6 million, or nearly 15 percent of the total $24.9 million paid out. Among them is the dean of the Yale School of Medicine, Dr. Robert Alpern, who received $445,398 in 2015 from two companies – Abbott Laboratories and AbbVie – in consulting fees, meals and travel expenses for serving on the boards of both companies. In 2014, he received $458,194 from the two companies. The Yale medical school began a research partnership with AbbVie in 2013, after the pharmaceutical company spun off from Abbott Laboratories.

Rise In Pregnancy-Related Deaths Is Shameful

About 650 U.S. women die each year during pregnancy, childbirth, or shortly after giving birth, according to the Centers for Disease Control and Prevention. Compared to other countries – and not just newly developing ones – that figure is abysmal. In fact, according to a new study from the World Health Organization and others, the U.S. is one of just 13 countries where the maternal mortality rate has actually risen between 1990 and 2013. Other countries on that list include North Korea and Zimbabwe. The gross domestic product of Zimbabwe is $13.5 billion.

Doctors, Clinicians, Team Up For C-HIT Forum On Preventive Care, Oct. 7

Doctors and clinicians from a wide array of specialties will offer their insights about the importance of preventive care at an upcoming community health forum in Hartford, featuring a keynote address by Dr. Jewel Mullen, commissioner of the Connecticut Department of Public Health. “Get Health Wise: The Benefits of Preventive Care” on Oct. 7, hosted by the Conn. Health I-Team, will give attendees the opportunity to hear presentations from doctors and clinicians at various health care stations. A panel discussion – with a question and answer period – will follow.

Can The FDA Adequately Police Generics?

As the federal government advocates increased use of generic drugs, concerns are mounting about the U.S. Food and Drug Administration’s oversight and the quality or effectiveness of some generics. In the last eight months, the FDA has acknowledged that two generic versions of the attention-deficit/hyperactivity disorder drug Concerta it approved may not work as effectively as the brand-name product. The agency told the drugs’ manufacturers to confirm their effectiveness or withdraw them from the market. The FDA also is looking into findings by a researcher at Boston’s Brigham and Women’s Hospital that generic versions of Pfizer’s cholesterol-lowering drug Lipitor manufactured outside of the U.S. contains impurities that inhibit the drug’s therapeutic effect. The FDA said that, as a number of popular drugs come off patent through 2015, it lacks the resources to independently police generics.

Report: Women In CT Denied Some Mandated Health Benefits

Women in Connecticut have been denied health insurance benefits in violation of the federal Affordable Care Act, according to a study by the National Women’s Law Center. Connecticut is one of 15 states included in the study, which analyzed the 2014 and 2015 health plans of companies that provide coverage under the ACA in state marketplaces. It found violations in all 15 states and concluded that they are likely occurring nationwide. According to the report, Connecticut women have been denied coverage for the following: breastfeeding counseling and education after two months following delivery, infertility treatments after the age of 40, sterilization procedures, emergency birth control, and maintenance care for such things as lupus, HIV, and hormones after breast cancer treatment. Coverage was also denied for transgender transitions.

ACA Court Challenge: What’s At Stake For Connecticut

Tens of thousands of Connecticut residents who receive federal subsidies to help pay for health insurance won’t be affected immediately by the latest challenge to the Affordable Care Act before the U.S. Supreme Court. But experts say there’s a good chance Connecticut residents will experience some political fallout from the court decision – which could come as soon as Thursday – challenging the validity of federal premium tax credits to 6.4 million Americans in 34 states with federally operated insurance marketplaces (also known as exchanges). Nearly 74 percent (74,682) of the 101,294 people who purchased commercial health insurance plans through Access Health CT (AHCT) received federal subsidies, as of June 2015. Connecticut is among the 16 states – along with the District of Columbia – that established their own state-based marketplaces through the health law. A court decision that blocks health insurance subsidies in the federally-operated marketplaces could lead to “some crazy maneuvering at the federal level from a legislative perspective that could impact Connecticut” if Congress moves to repeal or significantly modify the law, said James Wadleigh, chief executive officer of AHCT.